According to the results of in vitro and in vivo experiments, Fzd2 is an oncogene, and overexpression of Fzd2 and signaling through the non-canonical Wnt pathway can promote the development of advanced metastatic cancer [28]. This evidence concerns the gene FZD2 and metastatic malignant neoplasm.